Evidence map›Paper›PMID 23199016›Full record

ArticleInfluenza and other respiratory viruses2013

A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort.

Leslie S Kersun, Anne Reilly, Susan E Coffin, Jean Boyer, Eline T Luning Prak, Kenyetta McDonald, Xiaoling Hou, Abbas F Jawad, Kathleen E Sullivan

Open access · bronzeAbstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Leslie S KersunDivision of Oncology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.Division of Infectious Diseases, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.Division of Allergy Immunology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Anne Reilly
Susan E Coffin
Jean Boyer
Eline T Luning Prak
Kenyetta McDonald
Xiaoling Hou
Abbas F Jawad
Kathleen E Sullivan
Children's Hospital of Philadelphia · USUniversity of Pennsylvania · US

Funding

Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant RecipientsU01AI125135 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HALASA, NATASHA BASSAM · 2016 to 2018
$4.9M
IMMUNE FUNCTION AND BIODEFENSE IN CHILDREN. ELDERLY AND IMMUNOCOMPROMI-266050024N01AI050024 · NIAID · THE CHILDRENS HOSPITAL OF PHI · PI SULLIVAN, KATHLEEN · 2006 to 2006
–
NIAID NIH HHS N01-AI-50 024NIAID NIH HHS U01 AI125135
6 · The paper itself

Abstract

backgroundPediatric oncology patients represent a cohort of individuals uniquely at risk of complications from influenza, yet less likely to respond to the vaccine. It is not yet clear how to best protect this vulnerable population.

methodsWe performed a prospective analysis of 177 pediatric oncology patients to define the predictors of influenza vaccine responses. Each variable was examined over three time points and a repeated measure analysis was performed.

resultsPatients with ALL vaccinated during induction phase had superior influenza vaccine responses than those subjects vaccinated during post-induction or maintenance phases (P=0·0237). Higher aggregate HAI titer responses were associated with a higher baseline B-cell count (P=0·0240), and higher CD4 and CD8 influenza-specific T-cell responses, suggesting prior antigen exposure is a significant contributor. The solid tumor cohort had equivalent responses during all time frames of chemotherapy. DISCUSSION: The optimal protection from influenza of pediatric patients on chemotherapy should include vaccination, but it is clear that not all patients produce high titers of antibodies after vaccination. This study identified biomarkers that could be used to individualize vaccine approaches. Immunologic predictors might have a role in targeting resources, as B-cell counts predicted of vaccine responses among the patients with ALL.

Indexed as

AdolescentAntibodies, ViralAntineoplastic AgentsChildChild, PreschoolFemaleHemagglutination Inhibition TestsHumansInfantInfluenza, HumanInfluenza VaccinesLymphocytesMaleNeoplasmsProspective StudiesAntibodies, ViralAntineoplastic AgentsInfluenza VaccinesALLantibodyB cellELISPOTinfluenzavaccine

Identifiers

PMID23199016
PMCPMC4634289
OpenAlexW1566728753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.